TRIPLE NEGATIVE BREAST NEOPLASMS
Clinical trials for TRIPLE NEGATIVE BREAST NEOPLASMS explained in plain language.
Never miss a new study
Get alerted when new TRIPLE NEGATIVE BREAST NEOPLASMS trials appear
Sign up with your email to follow new studies for TRIPLE NEGATIVE BREAST NEOPLASMS, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New hope for tough breast cancer: experimental combo challenges standard treatment
Disease control Not yet recruitingThis study compares two different drug combinations for people with advanced triple-negative breast cancer who haven't had previous treatment. About 150 participants will receive either an experimental combination (sacituzumab govitecan plus toripalimab) or the current standard c…
Matched conditions: TRIPLE NEGATIVE BREAST NEOPLASMS
Phase: PHASE2 • Sponsor: Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University • Aim: Disease control
Last updated Mar 27, 2026 12:40 UTC
-
New drug combo strategy aims to outsmart advanced breast cancer
Disease control Not yet recruitingThis study is testing if alternating between two newer, targeted cancer drugs can help patients with advanced triple-negative breast cancer live longer than using just one of the drugs. It will involve about 260 adults whose cancer has spread or cannot be removed by surgery. The …
Matched conditions: TRIPLE NEGATIVE BREAST NEOPLASMS
Phase: PHASE2 • Sponsor: UNICANCER • Aim: Disease control
Last updated Mar 23, 2026 15:15 UTC